FMS freseniusmedicalcare.com: Price-to-Projected Revenue Ratio

Corporate company logo of Fresenius Medical Care (FMS)

The forward price-to-sales ratio for Fresenius Medical Care (FMS) demonstrates the evolution of market expectations, where the 0.40 mark indicates the current state of the metric. Previously, stability was maintained through the optimization of cross-border flows and hubs. Currently, growth is driven by global dominance in dialysis via AI analytics and vertical integration, leveraging a network of specialized plants and clinics worldwide.

Fresenius Medical Care AG - FMS Market Cap to Expected Sales Ratio (period 07/04/2022 - 11/14/2026)

Analytical breakdowns for Fresenius Medical Care

- current price and projected stock value:
Stock Price Fresenius Medical Care AG & Co. KGaA|FMS - Average Forecast Price
- company stock capitalization data:
Market Value Fresenius Medical|FMS - Business Value
- book value of equity indicators:
Book Value per Share Fresenius Medical Care|FMS - Book Valuation of Business|Market Cap to Net Assets Ratio freseniusmedicalcare.com|FMS - Company Total Assets
- company total debt and liquidity indicators:
Debt to Equity Fresenius Medical Care|FMS - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Ratio Fresenius Medical Care|FMS - Aggregate Debt Obligations|Debt to Book Capitalization Ratio Fresenius Medical|FMS - Company Long-Term Liabilities|Company Short-Term Debts Fresenius Medical Care|Quick Ratio freseniusmedicalcare.com
- financial results and valuation multiples details:
FMS - Company Profit|Projected Future Earnings Fresenius Medical Care|FMS - Business Payback Period|Forward P/E Multiple Fresenius Medical Care Corp|FMS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Fresenius Medical|FMS - Operating profit EBITDA|Earnings per share for the last twelve months Fresenius Medical Care|FMS - Earnings per share for the last twelve months|Year-over-year net earnings per share growth for the last 12 months freseniusmedicalcare.com|FMS - Earnings per share increase in current year|Earnings growth forecast for next year Fresenius Medical Care
- sales volume and revenue indicators:
FMS - Company Sales|Projected Sales Volume Fresenius Medical Care AG & Co. KGaA|FMS - P/S Multiple|Price-to-Projected Revenue Ratio Fresenius Medical
Summary company analysis:FMS (Fresenius Medical Care AG & Co. KGaA)
Original product of freseniusmedicalcare.com

The optimization of Fresenius Medical Care clinics and the expansion of home dialysis are driving future cash flows, as reflected in the forward price-to-sales multiple chart. This indicator compares current market capitalization with projected sales volume, allowing for a real-time assessment of market expectations without the lag of financial reporting. A declining ratio amid a stable business signals that the asset is undervalued, creating an entry point for long-term investors.

Competitors of Fresenius Medical Care (FMS)

Forward P/S Multiple HCA (HCA Healthcare)|Tenet Healthcare Corp (THC) - Market Cap to Future Revenue Ratio|SOLV - Price-to-Projected Revenue Ratio|EHC (Encompass) - Market Cap to Projected Revenue|UHS: Forward P/S Multiple|DVA - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple RDNT|Forward P/S Multiple Option Care|Price-to-Projected Revenue Ratio Surgery Partners Corp (SGRY)|Market Cap to Expected Sales Ratio Premier Health|National Vision Holdings - Forward Price-to-Revenue Multiple|Forward Price to Sales PGNY|ARDT - Price-to-Projected Revenue Ratio|Select Medical Corporation (SEM) - Forward Price-to-Revenue Multiple|ASTH: Forward P/S Multiple|Market Cap to Future Revenue Ratio MEDNAX (MD)|USPH (US Physical Therapy) - Forward P/S Multiple|Market Cap to Projected Revenue PNTG (pennantgroup.com)|Forward P/S Multiple ORGO|Market Cap to Expected Sales Ratio Nutex Health Inc|Forward P/S Multiple AUNA (Auna Health)|SBC - Forward Price-to-Revenue Multiple|Evolus, Inc. - Forward P/S Multiple|CYH - Forward P/S Multiple|beautyhealth.com (SKIN) - Price-to-Projected Revenue Ratio|MDWD (MediWound) - Price-to-Projected Revenue Ratio|Forward Price-to-Revenue Multiple BTMD|JYNT: Forward Price to Sales|Forward P/S Multiple DCGO|Forward Price-to-Revenue Multiple p3hp.org PIII|Forward P/S Multiple GANX (Gain Therapeutics)|Forward P/S Multiple EUDA Health Holdings EUDA|BMGL - Price-to-Projected Revenue Ratio|Forward Price to Sales CLGN (CollPlant Biotechnologies)|CUPR: Forward P/S Multiple|Market Cap to Future Revenue Ratio concordmedical.com (CCM)|AMS (American Shared Hospital Services) - Forward P/S Multiple|MEDIROM Healthcare Group Inc. - Future Price to Revenue|Price-to-Projected Revenue Ratio Avalon GloboCare (ALBT)|Forward Price-to-Revenue Multiple DIH Group DHAI|Price-to-Projected Revenue Ratio Longevity Health Holdings XAGE|Market Cap to Expected Sales Ratio newgenivf.com (NIVF)|ATIP: Forward Price-to-Revenue Multiple|CareMax Inc. - Price to Expected Revenue Ratio|Kindly MD Corp (KDLY) - Price-to-Projected Revenue Ratio|ModivCare Corp - Forward Price to Sales|NVOS (Novo Integrated Sciences) - Forward P/S Multiple|Market Cap to Future Revenue Ratio SunLink Health Systems, Inc SSY|Forward P/S Multiple BACK